Market News Archives

Steve Ballmer’s Intuit Dome Unveiled: $2 Billion HQ Redefines Sports Arenas and Corporate Campuses -( $INTU $MSFT $SPY )

by Vista Partners LLC November 18, 2025 1092Views 0Likes

Intuit’s (INTU) latest splash isn’t in fintech, but in construction—where the budget now garners more buzz than its balance sheet. Yes, the $2 billion figure making headlines isn’t another buyback authorization or a Silicon Valley campus remodel: It’s the sticker price for…

Wall Street Indices Slide as Investors Await Nvidia Earnings – Nov. 17, 2025 -( $EPRX $GOOG $INTG $JAZZ $JNJ $PACS $VIX Rise!)

by Vista Partners LLC November 18, 2025 2791Views 0Likes

Monday was a classic "hold your horses" day, with Wall Street digesting fresh economic data, tariff news, and awaiting Nvidia’s AI-focused earnings report later this week. Stock indices retreated modestly but maintain strong YTD performance, investors eyeing the yield curve and FOMC…

Blue Origin’s Space Data Centers: The Next Big Leap for AI Infrastructure -( $AMZN $SPY $TSLA )

by Vista Partners LLC November 17, 2025 603Views 0Likes

Blue Origin’s CEO, Dave Limp, has sparked industry attention with his stunningly candid forecast: the world’s biggest AI-optimized data centers will soon decamp from the plains of Utah and the forests of Oregon for the final, distinctly real frontier—outer space. Driven by…

Modular Medical Gains IRB Green Light for Next-Gen Tubeless Insulin Delivery Device -( $MODD )

by Vista Partners LLC November 17, 2025 692Views 0Likes

Modular Medical (NASDAQ: MODD) is injecting fresh ambition into the world of diabetes care, touting Institutional Review Board (IRB) approval to deliver insulin with its Pivot™ tubeless patch pump to adult study participants just as the company pursues FDA clearance for commercial…

J&J’s $3 Billion Bet: Halda’s Cancer Tech Joins the Pharma Powerball Acquisition Parade -( $JNJ $RNA $NVS $AZN $DIA)

by Vista Partners LLC November 17, 2025 654Views 0Likes

Johnson & Johnson (JNJ) made headlines with its definitive agreement to acquire Halda Therapeutics, a privately head clinical-stage biotech company famed for its Regulated Induced Proximity Targeting Chimera (RIPTAC) platform, in a $3.05 billion cash deal. The strategic move, set to strengthen…

Opendoor Unveils Special Dividend as Shares Skyrocket: Real Estate Gets a Dose of Silicon Savvy -( $OPEN $SPY $QQQ )

by Vista Partners LLC November 16, 2025 585Views 0Likes

Opendoor Technologies Inc. (NASDAQ: OPEN), the online real estate platform that once made home flipping look like flipping pancakes, has now flipped its script to become an artificial intelligence-driven enterprise, sending its stock soaring nearly 24% ahead of a special dividend announcement.…

Merck Mixes Up Its Pipeline With Cidara $9.2B Acquisition—GeoVax Keeps Driving Towards Value in the Vaccine Lane -( $MRK $CDTX $GOVX $IBB )

by Vista Partners LLC November 15, 2025 663Views 0Likes

Merck (MRK), ever the discerning giant of Big Pharma, has decided to join the prophylactic party by acquiring Cidara Therapeutics (CDTX) for a headline-grabbing $9.2 billion—a move that whispers both “strategic pipeline expansion” and “Keytruda’s patent clock is ticking, folks.” In a…

Wall Street’s Cha-Cha: Shutdowns, Surges, and Market Shenanigans—Weekly Market Wrap, Nov. 14, 2025 -( $AAPL $CDTX $EPRX $LLY $MCD $MODD $MRK $MTWO $NVDA $OPEN $RIO $SER $WHSP Rise!)

by Vista Partners LLC November 14, 2025 2608Views 0Likes

If scorekeepers gave points for wit, this week would earn an honorable mention—showcasing the market’s ability to sprint, stumble, and get up again before anyone starts playing the national anthem. Investors, however, are left pondering what comes next, armed with quarterly reports,…

Modular Medical’s Tubeless Insulin Patch Pump Races Toward FDA Review: Can Simplicity Dominate a $3 Billion Market? -( $MODD )

by Vista Partners LLC November 14, 2025 1175Views 0Likes

Modular Medical (NASDAQ: MODD) recently ramped up the news cycle with a flurry of regulatory milestones, engineering feats, and even a bit of C-suite global musical chairs—all tailored to make insulin delivery as easy as changing your socks (and almost as affordable).…

Eupraxia Bets on Durable Signals as Pipeline Optionality Grows

by Vista Partners LLC November 14, 2025 652Views 0Likes

In a biotech climate where milestones arrive with the precision of a quarterly forecast and often carry as much suspense as a regulatory ruling, Eupraxia Pharmaceuticals (NASDAQ: EPRX) unveiled (after the close on Nov. 13) new 52-week follow-up data from its RESOLVE…

Market News

Your Guide To Staying Informed In The Markets